+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Preimplantation Genetic Testing Market - Global Forecast 2026-2032- Product Image
Preimplantation Genetic Testing Market - Global Forecast 2026-2032- Product Image
New

Preimplantation Genetic Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968718
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The preimplantation genetic testing market has become a focal point for leaders in diagnostics, fertility, and genomics, spurred by fast-paced technological advances and heightened regulatory complexity. Senior decision-makers are tracking this evolving landscape to align clinical effectiveness with operational and commercial priorities, positioning their organizations for long-term competitive strength.

Market Snapshot: Preimplantation Genetic Testing Market Overview

The preimplantation genetic testing market advanced from USD 875.01 million in 2025 to USD 981.15 million in 2026, with further expansion projected at a CAGR of 12.36% to reach USD 1.97 billion by 2032. This sustained growth trajectory reflects accelerated clinical adoption, steady integration of emerging technologies, and the impact of regulatory and payer dynamics. Stakeholders are navigating a landscape characterized by new business models, operational efficiencies, and the imperative to address evolving patient expectations in reproductive medicine.

Scope & Segmentation

This report delivers a comprehensive analysis of the preimplantation genetic testing market, detailing its core segments, technology trends, and regional dynamics. Understanding these segments helps decision-makers tailor strategies to optimize market entry, partnership development, and clinical innovation.

  • Testing Types: Assessments cover PGT-A for aneuploidy, PGT-M for monogenic disorders, and PGT-SR for structural rearrangements. Each type requires unique regulatory pathways and presents different value propositions for patient management.
  • Diagnostic Pathways: The analysis distinguishes between Preimplantation Genetic Diagnosis (for single-gene and inherited conditions) and Preimplantation Genetic Screening (broad chromosomal checks), each requiring specific clinical coordination and patient communication workflows.
  • Technologies: Platforms include Comparative Genomic Hybridization, Fluorescent In-Situ Hybridization, Next-Generation Sequencing, PCR-based testing, and Single-Nucleotide Polymorphism analysis. The chosen technology impacts data complexity, laboratory throughput, and quality assurance requirements.
  • Offerings: Market components are instruments, reagents and consumables, and software solutions. Each category shapes business models and influences procurement and partnership priorities for laboratories and clinics.
  • End Users: The focus covers diagnostic laboratories, fertility clinics, hospitals, and research institutes. Their operational models and strategic collaborations determine adoption patterns and service innovation.
  • Regions Covered: Analysis spans the Americas, Europe, Middle East and Africa, and Asia-Pacific, with a focus on infrastructure readiness, reimbursement approaches, and localization strategies.

Key Takeaways

  • Hybrid technology adoption is transforming diagnostic service bundles, requiring labs to deploy sequencing, PCR, and SNP-based platforms for improved accuracy and efficiency.
  • Increasing regulatory oversight prompts investments in quality systems, evidence development, and clinical validation, which are crucial as payer requirements for tangible clinical benefits rise.
  • Patient demand for actionable genetic insights and robust counseling is prompting closer alignment between labs and clinics, ensuring comprehensive pre- and post-test support.
  • Distinct regional environments necessitate tailored go-to-market approaches. Asia-Pacific and EMEA regions are seeing gains through centralized testing hubs and international collaborations, adjusting for local payer and regulatory norms.
  • Strategic collaborations among instrument providers, reagent suppliers, and reference labs support bundled solutions, lowering adoption barriers and enhancing clinical delivery and operational efficiency.

Tariff Impact

Recent U.S. tariff measures introduced in 2025 have significantly altered sourcing and procurement strategies throughout the preimplantation genetic testing sector. In response, laboratories and vendors have adapted by pursuing supplier diversification, nearshoring, and multi-sourcing to manage tariff-related risks. This evolution has informed platform selection and encouraged the development of contract models where partners share supply chain risk. Manufacturers are increasingly evaluating local production and alternative suppliers to ensure inventory resilience and continuity in light of shifting trade policies.

Methodology & Data Sources

This analysis is built on primary interviews with clinicians, lab directors, and payers, combined with a thorough review of clinical publications and regulatory documents. Triangulation across data sources yields reliable recommendations, further verified through internal peer review and standard compliance checks.

Why This Report Matters

  • Enables strategic planning by revealing how diagnostics, technology, and regulation shape commercialization and partnership prospects.
  • Guides effective supply chain and procurement decisions through in-depth tariff impact review and technology evaluation.
  • Delivers operational insight for blending clinical, technological, and regional priorities to secure robust market positioning and improved patient outcomes.

Conclusion

Organizations that align platforms with clinical needs, reinforce supply chain and regulatory agility, and prioritize adaptable, clinician-centered solutions will be best equipped to capture opportunity and realize sustainable market value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Preimplantation Genetic Testing Market, by Test Type
8.1. PGT-A (Aneuploidy)
8.2. PGT-M (Monogenic Disorders)
8.3. PGT-SR (Structural Rearrangements)
8.4. PGT-HLA (Human Leukocyte Antigen Matching)
9. Preimplantation Genetic Testing Market, by Technology Type
9.1. Comparative Genomic Hybridization
9.2. Fluorescent In-Situ Hybridization
9.3. Next-Generation Sequencing
9.4. PCR-Based Testing
9.5. Single-Nucleotide Polymorphism
10. Preimplantation Genetic Testing Market, by Offering
10.1. Instruments
10.2. Reagents & Consumables
10.2.1. Kits
10.2.2. Probes
11. Preimplantation Genetic Testing Market, by Procedure Stage
11.1. Embryo Biopsy
11.2. Polar Body Biopsy
11.3. Blastocyst Biopsy
12. Preimplantation Genetic Testing Market, by Application
12.1. Aneuploidy Screening
12.2. Monogenic Diseases
12.3. IVF Prognosis
13. Preimplantation Genetic Testing Market, by End User
13.1. Diagnostic Laboratories
13.2. Fertility Clinics
13.3. Hospitals
13.4. Research Institutes
14. Preimplantation Genetic Testing Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Preimplantation Genetic Testing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Preimplantation Genetic Testing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Preimplantation Genetic Testing Market
18. China Preimplantation Genetic Testing Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Agilent Technologies, Inc.
19.7. Bio-Techne Corporation
19.8. Bioarray S.L.
19.9. EUROPE IVF International s.r.o.
19.10. F. Hoffmann-La Roche AG
19.11. Genea Limited
19.12. GENETiKS
19.13. Illumina, Inc.
19.14. Invicta Genetics
19.15. Invitae Corporation
19.16. Juno Genetics, US Inc.
19.17. Laboratory Corporation of America Holdings
19.18. MedGenome Labs Ltd.
19.19. Merck KGaA
19.20. Natera, Inc.
19.21. NextGen Genetics Holdings, LLC
19.22. Ovation Fertility
19.23. PacGenomics
19.24. PerkinElmer, Inc.
19.25. Progyny, Inc.
19.26. Qiagen N.V.
19.27. Quest Diagnostics Incorporated
19.28. Reproductive Genetic Innovations, LLC
19.29. SEQUENCE46, LLC
19.30. Sysmex Corporation
19.31. Takara Bio Inc.
19.32. The Cooper Companies Inc.
19.33. Thermo Fisher Scientific Inc.
19.34. Vitrolife Sweden AB
19.35. Yikon Genomics (Shanghai) Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-A (ANEUPLOIDY), BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-A (ANEUPLOIDY), BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-A (ANEUPLOIDY), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-M (MONOGENIC DISORDERS), BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-M (MONOGENIC DISORDERS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-M (MONOGENIC DISORDERS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-SR (STRUCTURAL REARRANGEMENTS), BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-SR (STRUCTURAL REARRANGEMENTS), BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-SR (STRUCTURAL REARRANGEMENTS), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-HLA (HUMAN LEUKOCYTE ANTIGEN MATCHING), BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-HLA (HUMAN LEUKOCYTE ANTIGEN MATCHING), BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-HLA (HUMAN LEUKOCYTE ANTIGEN MATCHING), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENT IN-SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENT IN-SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENT IN-SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PCR-BASED TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PCR-BASED TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROBES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROBES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY EMBRYO BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY EMBRYO BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY EMBRYO BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY POLAR BODY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY POLAR BODY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY POLAR BODY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY BLASTOCYST BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY BLASTOCYST BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY BLASTOCYST BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY ANEUPLOIDY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY IVF PROGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY IVF PROGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY IVF PROGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 114. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 115. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 116. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 117. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 129. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 131. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 132. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 133. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 146. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 147. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 148. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 149. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 150. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. ASEAN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 154. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 155. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 156. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 157. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 158. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. GCC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 170. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 171. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 172. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 173. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 174. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. BRICS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 178. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 179. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 180. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 181. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 182. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. G7 PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 186. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 187. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 188. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 189. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 190. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. NATO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 198. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 202. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 203. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
TABLE 204. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 205. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 206. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PROCEDURE STAGE, 2018-2032 (USD MILLION)
TABLE 207. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. CHINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Preimplantation Genetic Testing market report include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Techne Corporation
  • Bioarray S.L.
  • EUROPE IVF International s.r.o.
  • F. Hoffmann-La Roche AG
  • Genea Limited
  • GENETiKS
  • Illumina, Inc.
  • Invicta Genetics
  • Invitae Corporation
  • Juno Genetics, US Inc.
  • Laboratory Corporation of America Holdings
  • MedGenome Labs Ltd.
  • Merck KGaA
  • Natera, Inc.
  • NextGen Genetics Holdings, LLC
  • Ovation Fertility
  • PacGenomics
  • PerkinElmer, Inc.
  • Progyny, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • SEQUENCE46, LLC
  • Sysmex Corporation
  • Takara Bio Inc.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife Sweden AB
  • Yikon Genomics (Shanghai) Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 981.15 Million
Forecasted Market Value ( USD ) by 2032 $ 1970 Million
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Preimplantation Genetic Testing Market Report 2025 - Product Image

Preimplantation Genetic Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Preimplantation Genetic Testing Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Preimplantation Genetic Testing Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Preimplantation Genetic Testing Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Preimplantation Genetic Testing Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 107 Pages
  • Global
From
Preimplantation Genetic Testing Market by Product & Service, Technology, Procedure, Application, Type of Cycle - Global Forecast to 2030 - Product Image

Preimplantation Genetic Testing Market by Product & Service, Technology, Procedure, Application, Type of Cycle - Global Forecast to 2030

  • Report
  • 415 Pages
  • Global
From
Preimplantation Genetic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Preimplantation Genetic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 199 Pages
  • Global
From

About the Market

Preimplantation Genetic Diagnosis (PGD) is a biotechnology procedure used to detect genetic abnormalities in embryos prior to implantation. It is used in conjunction with in vitro fertilization (IVF) to help couples with a family history of genetic disorders or those at risk of transmitting a genetic disorder to their offspring. PGD involves the removal of a single cell from an embryo and testing it for genetic abnormalities. The results of the test are then used to determine which embryos are suitable for implantation. PGD has been used to detect a wide range of genetic disorders, including cystic fibrosis, Down syndrome, and Huntington's disease. It has also been used to detect chromosomal abnormalities, such as aneuploidy, which can lead to miscarriage or birth defects. PGD has been used to select embryos for gender selection, as well as to select embryos for tissue typing for bone marrow transplantation. Companies in the Preimplantation Genetic Diagnosis market include Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Agilent Technologies, Inc., and Natera, Inc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.